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ABSTRACT
Microarray-based pooled DNA methods overcome
the cost bottleneck of simultaneously genotyping
more than 100000 markers for numerous study indi-
viduals. The success of such methods relies on
the proper adjustment of preferential amplification/
hybridization to ensure accurate and reliable allele
frequency estimation. We performed a hybridization-
based genome-wide single nucleotide polymorph-
isms (SNPs) genotyping analysis to dissect prefer-
ential amplification/hybridization. The majority of SNPs
had less than 2-fold signal amplification or suppre-
ssion, and the lognormal distributions adequately
modeled preferential amplification/hybridization
across the human genome. Comparative analyses
suggested that the distributions of preferential
amplification/hybridization differed among geno-
types and the GC content. Patterns among different
ethnic populations were similar; nevertheless, there
were striking differences for a small proportion
of SNPs, and a slight ethnic heterogeneity was
observed. To fulfill appropriate and gratuitous
adjustments, databases of preferential amplification/
hybridization for African Americans, Caucasians and
Asians were constructed based on the Affymetrix
GeneChip Human Mapping 100 K Set. The robust-
ness of allele frequency estimation using this
database was validated by a pooled DNA experi-
ment. This study provides a genome-wide investi-
gation of preferential amplification/hybridization
and suggests guidance for the reliable use of the
database. Our results constitute an objective foun-
dation for theoretical development of preferential
amplification/hybridization and provide important
information for future pooled DNA analyses.
INTRODUCTION
Large-scale international human genomic/genetic studies,
such as the Human Genome Project (1), International Hap-
Map Project (2) and ENCODE Project (3), have contributed
to the further understanding of the human genome and
genetic disorders. These breakthroughs were made mainly
possible by the advent of mature genotyping techniques
[e.g. MALDI-TOF mass spectrometry (4) and oligonucleotide
microarrays (5)].
Although, high-throughput genotyping techniques are read-
ily available, the cost is still very high for large-scale genetic
studies that usually involve two high-dimension variables,
i.e. large sample sizes and a large number of genetic markers.
Thus, the development of pooled DNA experiment (allelo-
typing) technology would help reduce the cost associated
with large sample sizes. Allelotyping involves mixing
genomic DNAs from different study subjects to reduce the
number of samples, and it is an economical alternative com-
pared with individual genotyping experiments. Allelotyping
has been broadly used in disease gene association mapping
(6–11), polymorphism identiﬁcation/validation (12–15), and
analysis of genetic diversity (16,17). This technique has
been used to type single nucleotide polymorphisms (SNPs)
(18–20), short tandem repeat polymorphisms (STRPs) (21),
and restriction fragment length polymorphisms (RFLPs)
(22). The use of allelotyping in these methods has been com-
prehensively reviewed (23,24).
On the other hand, the need to reduce the cost of genotyp-
ing large numbers of SNPs has prompted the development
of modern microarray-based genotyping methods (5,25).
For example, the Affymetrix GeneChip Human Mapping
100 K Set provides genome-wide genotyping for each indi-
vidual using only a set of two dense oligonucleotide arrays
(26). This technique greatly reduces the costs of primer
design and assay reagents. Integration of pooled DNA experi-
ments and microarray-based genotyping creates a very cost-
effective and high-throughput marker-typing platform for
conducting large-scale genetic studies (27–32).
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doi:10.1093/nar/gkl446The success of a pooled DNA experiment mainly relies on
the accurate and reliable estimation of allele frequencies of
genetic markers. The estimation procedure mustly consider
an adjustment for an imbalance of nucleotide reaction—
referred to as ‘preferential ampliﬁcation’ and/or ‘differential
hybridization’. Preferential ampliﬁcation/hybridization is a
function of the characteristics of different nucleotides. It is
a natural phenomenon that could occur during several typing
stages, such as PCR ampliﬁcation, primer extension, array
hybridization or signal detection (23,33), and its magnitude
is quantiﬁed as the coefﬁcient of preferential ampliﬁcation/
hybridization (CPA) (34,35). As the name suggests, preferen-
tial ampliﬁcation/hybridization means that one allele tends
to be ampliﬁed or hybridized more efﬁciently than another.
Thus, for heterozygous individuals the ﬂuorescence intensity
of two alleles containing a SNP may differ. By deﬁnition,
CPA is the ratio of average peak intensities of two alleles.
A CPA > 1 indicates that the ﬁrst allele tends to be ampliﬁed/
hybridized more efﬁciently than the second allele; when
CPA ¼ 1, there is no preferential ampliﬁcation/hybridization;
if CPA < 1, the ﬁrst allele tends to be ampliﬁed/hybridized
less efﬁciently than the second one. This factor might have
little impact on genotype calling for individual genotyping;
however, it distorts the estimation of allele frequency in
DNA-pooling allelotyping, where allele frequencies are esti-
mated by calculating relative peak intensities of two alleles
accumulated in a DNA pool.
In a pooled DNA study, allele frequency estimates are
biased if adjustments are not made for preferential
ampliﬁcation/hybridization. This issue has generated much
research interest (34–36). Under a feasible pooled
DNA experiment, the estimation bias relates to the extent
of preferential ampliﬁcation/hybridization and ratio of
peak intensities (RPI) of two alleles (Figure 1). For example,
the positive (negative) bias for CPA ¼ 2 and RPI ¼ 1
(CPA ¼ 0.5 and RPI ¼ 1) is about 0.17 for allele frequency
estimation, and the positive (negative) bias for CPA ¼ 4 and
RPI ¼ 1 (CPA ¼ 0.25 and RPI ¼ 1) is about 0.30.
In many studies, additional heterozygous individuals
have been collected to perform a CPA adjustment
(7,35,37). Moreover, for two kinds of genotyping
experiments—sequential genotyping and large-scale
genotyping—one can calculate the required number of het-
erozygous individuals to yield a reasonably accurate and
precise estimation of CPA (34). The required number of
heterozygotes follows a negative binomial distribution in
the former experiment and a binomial distribution for the
latter. Allele frequency and RPI variability affect the
required number of heterozygotes. A SNP with a low
minor allele frequency and/or high RPI variability requires
a large number samples to attain the necessary precision.
However, additional genotyping of large numbers of het-
erozygous individuals increases both cost and effort. Thus,
the construction of a central resource (38) for information
on preferential ampliﬁcation/hybridization or the use of a
robust empirical estimation (36) would help diminish the
cost of experimentation.
In the present study, we surveyed the distribution of CPA
across the human genome and established a statistical model
for CPA. We have constructed a publicly available database
of CPA for different ethnic populations, and we suggest
guidance for the use of CPA in DNA pooling studies. The
robustness of allele frequency estimation using the database
was validated by a pooled DNA experiment.
Figure 1. Relationships among CPA, estimation bias and RPI. (A) Both CPA and RPI are between 0.01 and 1. (B) CPA is between 1 and 5, and RPI is between
0.01 and 1. (C) CPA is between 0.01 and 1, and RPI is between 1 and 100. (D) CPA is between 1 and 5, and RPI is between 1 and 100.
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Study subjects
The study included 199 subjects from two panels of data. The
ﬁrst panel included 95 samples from the Taiwan Han Chinese
Cell and Genome Bank (39). The second panel included 42
Caucasians, 42 African Americans and 20 East Asians from
the Human Variation Panel (Coriell Cell Repositories). All
subjects were genotyped using the Affymetrix GeneChip
Human Mapping 100 K Set. Subjects in the ﬁrst panel were
genotyped by the National Genotyping Center (http://ngc.
sinica.edu.tw) at Academia Sinica in Taiwan. Subjects in
the second panel were genotyped by Affymetrix, Inc., and
the data are available for download (no fee) upon request
at http://www.affymetrix.com/support/technical/byproduct.
affx?product=100k. Eighty-seven individuals with the best
DNA quality from the ﬁrst panel were selected to form a
DNA pool for an allelotyping experiment.
Genotyping and genetic data
For each subject, leukocyte genomic DNA was isolated from
10 ml of blood using the Puregene genomic DNA puriﬁcation
kit (Gentra Systems, MN, USA). The genotyping procedure
mainly followed the GeneChip Mapping Assay Protocol in
the Affymetrix GeneChip Mapping 100 K Assay Manual
(Affymetrix, CA). For each subject, a genotyping reaction
was performed with a total of 500 ng of genomic DNA.
And, 250 ng of DNA was processed by restriction enzyme
digestion with XbaI and HindIII, respectively, followed
by adapter ligation, PCR ampliﬁcation, fragmentation, end-
labeling and hybridization to microarray chips. After wash-
ing, ﬂuorescence hybridization signals were captured using
a GeneChip Scanner 3000 (Affymetrix, CA).
For each SNP genotyping, sense-strand (SS) probes and
antisense-strand (AS) probes were included in seven pairs
of probe quartets; each quartet contained a probe pair for
each allele of a given SNP. Each probe pair contained perfect
match (PM) and mismatch (MM) probe cells. Only ﬁve pairs
of high-quality probe quartets (40 ﬂuorescence signals) were
selected for genotype determination. The genotype calls of
SNPs were determined using the Dynamic Model (DM) algo-
rithm (40) contained in the software GCOS version 1.2 and
GDAS version 3.0 (Affymetrix). The Affymetrix GeneChip
Human Mapping 100 K Set contained 116 204 SNPs with a
median intermarker distance of 8.5 kb and average hetero-
zygosity of 0.3 (26). We calculated the call rate for the geno-
typing of each SNP. Only data from SNPs having call rates
>0.9 were included in the follow-up CPA analyses.
For pooled DNA allelotyping experiment, the DNA
concentration and quality of the selected 87 subjects were
determined using NanoDrop ND-1000 Spectrophotometer
(NanoDrop Technologies, DE). The integrity of DNA was
also assessed by using gel electrophoresis with a 0.8% agar-
ose gel. The pooling procedure was carried out by mixing
equal amount of DNA at the same concentration from each
individual sample. The ﬁnal concentration of the pooled
DNA was 50.06 ng/ml. A total of 500 ng of pooled DNA
was used for allelotyping using Affymetrix GeneChip
Mapping 100 K set following the genotyping procedure
described above.
Statistical analyses
CPAs were estimated using three methods: arithmetic mean
(35), bias-correction and geometric mean (34). Standard
errors and 95% conﬁdence intervals based on a bootstrapping
procedure with 1000 replications were calculated. Appendix
1 gives details on the procedures used to estimate CPA;
Appendix 2 contains information on the calculation of stan-
dard error and conﬁdence interval. The software Pooled
DNA Analyzer (PDA) (41) was used for the calculations.
Based on the bias-correction CPA, genomic distributions of
the estimated CPAs were investigated and model ﬁtting was
conducted based on the Shapiro–Wilks normality test (42)
with Holm’s multiple-test correction (43). Comparative stud-
ies of CPAs in log scale among different attribute groups
(chromosomes, nucleotides, GC content and SNP location)
were carried out using analysis of variance (ANOVA) anal-
ysis of regression (AOR) and analysis of covariance
(ANCOVA). Correlations of CPAs among different ethnic
populations were assessed by comparing Pearson correlation
coefﬁcients. The analyses were carried out using package
SAS/STAT version 8 (SAS Institute, NC). To evaluate the
performance of allele frequency estimation using CPAs,
three types of allele frequencies were estimated by using
PDA (41). Appendix 3 gives details on the allele frequency
estimation. Error rates and standard errors of the unadjusted
and adjusted allele frequency estimates were calculated, and
Pearson correlation coefﬁcient of the true and adjusted allele
frequencies was calculated.
RESULTS
Whole-genome distribution of CPA
Figure 2 shows representative results based on the combined
population containing 199 study subjects. These data present
a global view of all estimated CPAs across the 22 human
autosomes. For the whole genome, most of the estimated
CPAs ranged from 0.5 to 2. Median, mean and standard
error of the CPA estimate were 1.021, 1.077 and 0.368,
respectively, and the minimum and maximum CPA were
0.238 and 4.041. The sample mode of CPAs on different
chromosomes was  1.0 (Figure 3). Extremely over-ampliﬁed
or under-ampliﬁed alleles (by deﬁnition: CPA > 2 and
CPA < 0.5, respectively) were observed for 5.6% of all
SNPs. And the distribution of CPA was skewed to the
right. These results suggest that the CPA adjustments should
be applied to yield good estimates of allele frequency for
all SNPs; otherwise, a serious bias may occur—especially
for the SNPs with extreme CPAs (Figure 1).
The following sections offer a detailed discussion of the
patterns of CPAs considering four genetic factors: chromo-
somes, nucleotides, GC content and SNP location. Correla-
tions of CPAs among the three study populations are also
evaluated.
Relationships between CPA and chromosomes,
nucleotides, GC content and SNP location
The patterns of CPAs were quite similar across all autosomes.
Means, medians and standard deviations on different chromo-
somes were similar to those measured for the whole genome
(Figure 4A). The maximum and minimum averages of CPAs
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1.05, respectively (Table 1). One-way ANOVA showed that
there was no chromosome effect on the CPA distribution
(P ¼ 0.945).
Preferential ampliﬁcation/hybridization is mainly caused
by differences in PCR ampliﬁcation efﬁciency and hybrid-
ization and/or signal detection for alternative alleles. The
degree of differential efﬁciency may be highly correlated
with genotypes of target SNPs and percentage of GC content
of probes using the hybridization-based microarray genotyp-
ing platform. Box-whisker plots for different genotypes
(Figure 4B) showed that the maximum and minimum aver-
ages of CPAs were 1.272 and 0.891 for genotypes CT and
AG, respectively (Table 1). One-way ANOVA revealed that
the means of CPAs signiﬁcantly differed among different
genotypes (P < 0.0001). AOR showed signiﬁcant correlations
between CPA and the GC content of probes (P < 0.0001).
ANCOVA was applied to further investigate the relationship
between CPA and genotypes after accounting for differences
in GC content. Under these conditions, there were still signiﬁ-
cant differences in CPA among genotypes (P < 0.0001).
We further tested signal ampliﬁcation/suppression in
each genotype with respect to the 4 nucleotides, yielding
the following results: C > A (P < 0.0001), G > A (P <
0.0001), A > T (P < 0.0001), C > G (P < 0.0001), C > T (P
< 0.0001) and G > T (P < 0.0001). These results suggest the
relative ordering of signal ampliﬁcation as C > G > A > T,
where ‘>’ denotes ‘more efﬁciently ampliﬁed’. This ﬁnding
provides an empirical basis for modeling preferential
ampliﬁcation/hybridization in different genotypes.
SNPs have different biological implications depending
on their location in 30-untranslated regions (30-UTRs), 50-
UTRs, coding regions, introns or downstream/upstream of
genes. However, one-way ANOVA showed no signiﬁcant
difference in CPAs between SNPs located in these different
gene elements (P ¼ 0.4779). The patterns of CPAs
for SNPs in different locations were quite similar
(Figure 4C). The mean CPA measured for all of these
Figure 2. Scatter plots of the CPA estimates across the 22 human autosomes are given for a global view of the genome-wide CPA. The gap in each subfigure
reflects the centromeric gap. In each subfigure, three red reference lines are shown for CPA ¼ 2, 1 and 0.5 (from upper to lower).
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to 0.37 (Table 1).
Effect of ethnicity on CPA
Samples in this study contained three ethnic populations,
i.e. 42 African Americans, 42 Caucasians and 115 Asians
(20 samples from Affymetrix and 95 Taiwanese samples).
Pair-wise comparisons of CPAs among the three ethnic popu-
lations showed strong positive correlations (Figure 5); the
coefﬁcients of the Pearson correlation of CPAs between
‘African American and Caucasian’, ‘African American and
Asian’ and ‘Caucasian and Asian’ were 0.948, 0.920 and
0.902, respectively (Pearson correlation coefﬁcient of CPAs
between the 20 Asian samples from Affymetrix and 95
Taiwanese samples was 0.996). However, there were slight
discrepancies among ethnic populations and outliers. The
majority of CPA differences for the pair-wise comparisons
were between  1 and 1. A few striking differences between
different ethnic populations were observed. For example,
the maximum differences between ‘African American and
Caucasian’, ‘African American and Asian’ and ‘Caucasian
and Asian’ were 1.706, 2.119 and 2.092, respectively. The
CPA-distance between African Americans and Caucasians
was relatively smaller than the distance between either of
these groups and Asians.
Results of ethnic-differential-CPA SNPs (i.e. SNPs with
that an absolute value of a CPA difference between two
ethnic populations was greater than 1) were summarized.
The proportion of such SNPs across the human genome
was smaller than 1.3%. The majority of these SNPs showed
low minor allele frequencies (MAF) (Table 2). The propor-
tion of the ethnic-differential-CPA SNPs within the lowest
MAF bin (i.e. the MAF interval from 0 to 0.1) was ranged
from 45% to 59%, but that within the greatest MAF bin
(i.e. the MAF interval from 0.4 to 0.5) was <2%.
The high correlations of CPAs among different
ethnic populations suggest the transferability of CPA for
bias correction in most cases; however, the increased bias
and reduced test power due to the observed discrepancy
and a few CPA outliers suggest that an appropriate ﬁlter
should be applied prior to the analysis. Therefore, we
Figure 3. Histograms of CPA estimates across the 22 human autosomes show the distribution of CPA.
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CPAs and suggest criteria for their use. A large sample size
provides high reliability. The use of CPA from combined
samples is suggested when CPA discrepancies among
ethnic populations are small. However, a population-speciﬁc
CPA should be considered to avoid misuse of CPA.
The suggested criterion of SNP transferability between
two populations is jlnð^ k k1Þ lnð^ k k2Þj < ð1:96 · ^ s s
p
2
1 þ ^ s s2
2Þ,
where ^ k k1 and ^ k k2 are the estimated CPAs in two populations,
and ^ s s1 and ^ s s2 are the estimated standard errors of lnð^ k k1Þ
and lnð^ k k2Þ.
Model fitting for CPA
Statistical goodness-of-ﬁt procedures were carried out to
model CPAs. Distributions of CPAs were skewed toward
the right (Figures 3 and 5). The conjecture that CPAs in a
log scale follow a Gaussian distribution in each subgroup
was formally tested using the Shapiro–Wilks normality test
(42). More than 90% of the goodness-of-ﬁt tests passed the
normality check after Holm’s multiple-test correction (43),
which controls family-wise errors smaller than 1%, suggest-
ing that the following lognormal distributions provide a
good approximation to the CPA distributions:
fð^ k kÞ¼ð ^ k k^ s s 2
p
pÞ
 1 · expf  ½ð^ k k   ^ m mÞ/^ s s 
2/2g‚0< ^ k k<1‚
where the maximum likelihood estimators of mean and
variance of the estimated CPA ^ k k are exp½^ m m þð^ s s2/2Þ  and
½expf^ s s2g 1 ·expf2^ m m þ ^ s s2g, and ^ m m and ^ s s2 are the sample
mean and variance of lnð^ k kÞ, respectively. This ﬁnding
establishes an empirical basis for modeling preferential
ampliﬁcation/hybridization and provides support for theoreti-
cal development in pooled DNA analyses.
Figure 4. CPA distributions for important genetic factors. (A) CPA for
different chromosomes. (B) CPA for different genotypes. (C) CPA for
different SNP locations. Each subfigure presents box-whisker diagrams of
CPAs in different categories. The red line joins the medians of CPAs across
different categories. The extreme CPA values outside the 1.5 interquartile
range are indicated by blue dots.
Table 1. Descriptive statistics of CPA with regard to different factors
Number
of SNPs
Mean of
CPA
S.E. of
CPA
Maximum
of CPA
Minimum
of CPA
Chromosome
1 8955 1.077 0.364 3.177 0.238
2 10094 1.081 0.371 3.738 0.357
3 7618 1.076 0.357 2.894 0.350
4 8370 1.074 0.371 2.925 0.316
5 8143 1.078 0.368 3.148 0.346
6 7843 1.079 0.374 3.143 0.318
7 6802 1.078 0.374 3.064 0.332
8 6778 1.083 0.365 3.589 0.321
9 4665 1.073 0.359 3.428 0.387
10 5534 1.078 0.365 2.951 0.313
11 5239 1.072 0.365 4.041 0.348
12 5127 1.085 0.378 2.896 0.359
13 5073 1.077 0.376 3.084 0.273
14 3913 1.077 0.366 3.208 0.301
15 2961 1.078 0.368 3.647 0.249
16 2322 1.077 0.358 2.577 0.367
17 1916 1.068 0.357 2.839 0.280
18 3487 1.083 0.370 2.832 0.284
19 669 1.049 0.339 2.310 0.344
20 2032 1.072 0.367 3.213 0.370
21 1856 1.076 0.365 3.196 0.388
22 731 1.072 0.370 2.493 0.351
Genotype
AC 10002 0.916 0.292 2.902 0.283
AG 37489 0.891 0.280 3.738 0.238
AT 6761 1.077 0.275 2.848 0.249
CG 10572 1.079 0.333 3.065 0.316
CT 38237 1.272 0.370 4.041 0.273
GT 7067 1.239 0.374 3.208 0.365
Location
30-UTR 683 1.098 0.362 2.725 0.379
50-UTR 60 1.067 0.340 1.948 0.516
Coding region 655 1.067 0.340 2.751 0.350
Intron 38898 1.078 0.367 4.041 0.290
Downstream 32591 1.075 0.367 3.213 0.249
Upstream 37241 1.078 0.369 3.728 0.238
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We constructed a CPA database containing 116 204 SNPs for
use in future pooled DNA studies. The database provides
three types of information: (i) SNP descriptions (chromosome
number, probe set and physical position, genotype and SNP
location); (ii) results from all samples (SNP call rate, allele
frequency, locus heterozygosity, unadjusted and adjusted
P-values for the test of Hardy–Weinberg Equilibrium); (iii)
results from heterozygous individuals (number of heterozy-
gous individuals used in the CPA calculation, three CPA esti-
mates, the corresponding standard errors and 95% conﬁdence
intervals of CPA). The SNP information and annotation data
are publicly available from the Affymetrix website http://
www.affymetrix.com/support/technical/byproduct.affx?
product= 100k. Our database is now freely accessible online
at http://www.ibms.sinica.edu.tw/%7Ecsjfann/ﬁrst%20ﬂow/
database.htm; the interface is shown in Figure 6. Results
for genome-wide or chromosome-wide and combined-
population or population-speciﬁc analyses can be obtained
from the website. This database enables users to study and
adjust for preferential ampliﬁcation/hybridization in pooled
DNA analyses.
Evaluation of allele frequency estimation in
pooled samples
WecarriedoutpooledDNAallelotypingexperimentstoevalu-
ate the utility of our CPA database. Three types of allele fre-
quencies were calculated for comparison: (i) the estimated
allelefrequencybasedonunadjustedintensitydata;(ii)theesti-
mated allele frequency based on the bias-correction CPA
adjusted intensity data and (iii) the true allele frequency
based on individual genotyping result. With the CPA
adjustment, the bias of allele frequency estimation was obvi-
ously reduced (Figure 7 and Table 3). The error rate and stan-
dard error for the adjusted allele frequency estimates were
consistentlylowerthanthatfortheunadjustedestimates.More-
over, the adjusted and true allele frequencies showed a
high correlation of 0.99, demonstrating the good performance
Figure 5. The CPA distribution within each population and CPA discrepancy between any two different ethnic populations. The subfigures in the diagonal
show the CPA histograms in African Americans, Caucasians and Asians in order. The subfigures in the upper diagonal part are the scatter plots of CPAs between
any two ethnic populations. The subfigures in the lower diagonal part show the discrepancy of CPAs between any two ethnic populations.
Table 2. The distributions of ethnic-differential-CPA SNPs between two ethnic groups
MAF P{jCPA(African)-CPA(Caucasian)j > 1} P{jCPA(African)-CPA(Asian)j > 1} P{jCPA(Asian)-CPA(Caucasian)j > 1}
Percentage 1 Percentage 2 Percentage 1 Percentage 2 Percentage 1 Percentage 2
0.0–0.1 0.04 53.57 0.12 58.82 0.08 45.61
0.1–0.2 0.02 21.43 0.08 30.88 0.09 42.11
0.2–0.3 0.03 21.43 0.02 5.88 0.03 10.53
0.3–0.4 0.01 3.57 0.02 4.41 0.00 0.00
0.4–0.5 0.00 0.00 0.00 0.00 0.01 1.75
The distributions of ethnic-differential-CPA SNPs for African-Caucasian, African-Asian and Asian-Caucasian are shown in order. In each panel, the percentage in
thefirstcolumn(Percentage1)wascalculatedbydividingthenumberofethnic-differential-CPASNPsbythetotalnumberofSNPsintheMAFbin.Thepercentage
in the second column (Percentage 2) was calculated by dividing the number of ethnic-differential-CPA SNPs in a MAF bin by the total number of ethnic-
differential-CPA SNPs.
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estimation.
CONCLUSION AND DISCUSSION
In summary, preferential ampliﬁcation/hybridization plays
an important role in analyses that rely on ﬂuorescence inten-
sity data. The adjustment for preferential ampliﬁcation/
hybridization has been developed to estimate allele frequency
(34,35) and incorporated in test statistics for association
mapping (34,44) in pooled DNA analyses. The method has
been applied to microarray-based pooled DNA analysis
(29,30). Only a few papers provide systematic investigations
at preferential ampliﬁcation/hybridization. One study (36)
has discussed preferential ampliﬁcation based on 152 SNPs
genotyped using the platform SnaPshot (ABI, CA). Another
study (38) developed a database of adjustment index, R,
based on results from 100 Caucasians using the GeneChip
Human Mapping 10 K Array Set. Our study investigated
the whole-genome behavior of preferential ampliﬁcation/
hybridization based on  200 individuals using the GeneChip
Human Mapping 100 K Array Set. Instead of utilizing the
index R (38), our study focused on the index CPA because
it has been developed in rich literature (34,35,44) and broadly
used in practical applications (7,37,45). Our results show
that CPAs are dependent on the GC content of probes and
nucleotide characteristics based on ANOVA and AOR. More-
over, the results were conﬁrmed by four-way ANCOVA,
which simultaneously considers GC content, the effect of
nucleotides, chromosome and SNP location. The ﬁnding
that nucleotides G and C cause greater signal ampliﬁcation
compared with A and T is consistent with the principle that
base pairing strength for GC (three hydrogen bonds) is higher
than that for AT (two hydrogen bonds). Moreover, we found
Figure 6. The interface of our web-based CPA database. The first item provides an option for outputting either population-specific or combined-population
CPAs. The second option provides an option for outputting either chromosome-wide or genome-wide CPAs. Results can either be shown online or saved as an
html file.
Figure 7. Scatter plots of the unadjusted and adjusted allele frequencies
versus the true allele frequency. Each point denotes the coordinate of
estimated allele frequency versus true allele frequency for a SNP. The yellow
dots denote the results of the unadjusted allele frequency and green dots
denote the results of the adjusted allele frequency.
Table 3. Mean error rates and standard errors of the unadjusted allele
frequency and adjusted frequency estimates
True allele
frequency
Unadjusted estimate
of allele frequency
Adjusted estimate
of allele frequency
Mean error
rate
Standard
error
Mean error
rate
Standard
error
0.0–0.1 0.051 0.042 0.049 0.041
0.1–0.2 0.060 0.047 0.046 0.035
0.2–0.3 0.067 0.051 0.041 0.032
0.3–0.4 0.073 0.054 0.035 0.029
0.4–0.5 0.076 0.055 0.032 0.027
0.5–0.6 0.076 0.054 0.032 0.026
0.6–0.7 0.073 0.053 0.036 0.030
0.7–0.8 0.067 0.049 0.042 0.033
0.8–0.9 0.058 0.045 0.047 0.036
0.9–1.0 0.046 0.041 0.046 0.040
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future statistical modeling of CPA based on the distribution
can be supported empirically.
We also investigated the impact of ethnicity on the estima-
tion of preferential ampliﬁcation/hybridization. This issue has
never been investigated, although ethnic heterogeneity has
been recognized as a critically important factor in population
genetics and gene mapping studies (46,47). The CPA data
transferability or data combination was only suggested upon
a proper pre-selection. We constructed CPA databases based
on a high-density SNP panel for speciﬁc population and com-
bined population. To our knowledge, our study is the ﬁrst
to systematically discuss the whole-genome behavior of pre-
ferential ampliﬁcation/hybridization with consideration of
ethnicity for the CPA adjustment.
Association mapping is one of the important applications
of pooled DNA analyses. Pooled DNA association tests
compare differences in allele frequencies between case and
control groups. A fundamental assumption of this kind of
statistical test is that the two alleles relevant to a SNP are
independent, i.e. that they satisfy the Hardy–Weinberg
Equilibrium. Results of the association tests may be mis-
leading if the SNPs in question violate this assumption.
Therefore, in addition to marker information and CPA adjust-
ment, the CPA database also provides the measurement of
marker informativeness and veriﬁes the Hardy–Weinberg
Equilibrium. P-values for an exact test for the Hardy–
Weinberg Equilibrium (48), with or without consideration
of multiple comparisons, are provided to remind users of
potential violation of this principle.
Completion of DNA-pooling association mapping relies
on a well-established analytical system that includes
analysis strategy and user-friendly software. Previous work
established a multistage strategy consisting of adjustment of
preferential ampliﬁcation/hybridization, allele frequency esti-
mation, single-point association test, multipoint association
test and conﬁrmatory association test (24). The software
PDA (41) was designed to analyze data from allele-speciﬁc
genotypingandarray-basedgenotypingplatformsunderamul-
tistage framework. Integration of these free resources, namely
the CPA database, analytical strategy and PDA, provides a
powerful strategy with which to estimate allele frequency
and perform disease gene mapping in pooled DNA studies.
The costs and beneﬁts associated with genetic typing are
major concerns when assessing the feasibility of large-scale
genetic studies. New-generation methods for pooled DNA
analysis combine conventional DNA pooling techniques
with modern microarray-based genotyping methods to
meet cost-beneﬁt requirements and achieve high-throughput
and exceptional validity-reliability for large-scale genome
screens. Current pooled DNA methods hardly provide deta-
iled information for respective individuals, but such methods
are quite useful when studies focus on statistical/biological
inferences via allele frequency. Such methods are likely to
be applied broadly in future genetic studies.
We are extending this project in the several ways. (i)
We are increasing the sample size of heterozygous individu-
als. CPA can be estimated precisely using a modest number
of heterozygous individuals (34,35); nevertheless, more
heterozygous samples further increase the precision of CPA
estimation. Results of this study were established on the
basis of  200 individuals, and more samples are being col-
lected to enhance the study reliability. (ii) We are increasing
the density of SNP markers. We are extending the investiga-
tion of the GeneChip Human Mapping 100 K Array Set to the
Human Mapping 500 K Array Set. This new mapping panel
has a median intermarker physical distance of 2.5 kb and
average heterozygosity of 0.25; thus, it will provide more
than twice the genetic power and SNP content relative to
the 100 K Set, thereby facilitating ﬁne-speciﬁcity positional
cloning studies of complex disorders via pooled DNA
analyses (online document at http://www.affymetrix.com/
products/arrays/speciﬁc/500k.affx). (iii) We are extending
the study populations. Although, CPAs of the majority of
SNPs may be portable for different ethnic populations, the
application of population-speciﬁc data to other ethnic groups
runs the risk of increasing the estimation bias and reducing
the testing power for some SNPs. Thus, we are collecting
more samples from different groups to further expand the
applicability of our database. (iv) We are enlarging the pool
size. In addition to a pool size of 87, we have already carried
out pooled DNA allelotyping experiments with pool sizes
of 10, 30 and 50. The comparisons showed no signiﬁcant
differences of results among the considered pool sizes, indi-
cating that a pool size up to 87 was still within the applicable
range of this type of experiment. Therefore, we are enthu-
siastically conducting experiments with more samples to
investigate the limitation of pool size in microarray-based
pooled DNA experiments.
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APPENDIX
Appendix 1. The estimation of CPA
For each individual SNP, the intensity data contain 40 ﬂuore-
scent signals, [f(a, b, c, d), a 2 A, b 2 B, c 2 C, d 2 D], where
A ¼ {SS, AS}, B ¼ {PM,MM}, C ¼ {Allele1, Allele2} and
D ¼ {Quartet1,...,Quartet5}. Let nh denote the number of
heterozygous individuals. We introduce the CPA estimating
procedure, which was formulated using the feature extraction
procedure (25,30) and the bias-correction procedure (34).
In the feature extraction stage, let
f*ða‚PM‚c‚dÞ¼maxffða‚PM‚c‚dÞ 
1
2
X
t2C
fða‚MM‚t‚dÞ‚0g
denote the adjusted PM signal of strand a for allele c in the
dth quartet. The signals were calibrated by subtracting the
background noise measured by intensities of mismatched
cells. Based on the deﬁnition of relative allele signal (RAS)
(25), the RAS of allele c was a ratio of the ﬂuorescence signal
of the allele for perfectly matched cells as follows:
RASða‚PM‚c‚dÞ¼
f*ða‚PM‚c‚dÞ
P
t2Cf*ða‚PM‚t‚dÞ
:
Medians of RAS over ﬁve quartets for the sense and antisense
strands were calculated separately, and the mean of the two
medians yielded the individual RAS (IRAS) of the ﬁrst allele
for the ith individual as follows:
IRAS1ðiÞ¼
1
2
median
d¼1‚...‚5
fRASðSS‚PM‚1‚dÞg þ
1
2
median
d¼1‚...‚5
fRASðAS‚PM‚1‚dÞg‚i ¼ 1‚...‚nh and
IRAS2ðiÞ¼1   IRAS1ðiÞ:
The sample means of IRAS for allele 1 and allele 2 over all
heterozygous individuals were
IRAS1 ¼ n 1
h ·
X nh
i¼1
IRAS1ðiÞ
and IRAS2 ¼ n 1
h ·
Pnh
i¼1 IRAS2ðiÞ:
In the stage where CPA was estimated, Hoogendoorn’s
CPA (35) was calculated as follows:
^ k kH ¼ n 1
h ·
X nh
i¼1
½IRAS1ðiÞ/IRAS2ðiÞ :
The other two CPAs, unbiased CPA and geometric CPAs
(34), can be estimated as follows:
^ k kU¼^ k kHþ
nh
nh 1
IRAS1
IRAS2
 ^ k kH
  
and^ k kG¼
Y nh
i¼1
IRAS1ðiÞ
IRAS2ðiÞ
"# 1/nh
:
A reference allele (i.e. allele 2) must be speciﬁed while
CPA is estimated. Throughout this study, all heterozygous
genotypes were rearranged as the following six genotypes:
AC, AG, AT, CG, CT and GT. The second allele in each of
the previous six genotypes was regarded as the reference
allele.
Appendix 2. The standard error and empirical
distribution of the estimated CPA
We calculated the standard error of the estimated CPA based
on a bootstrapping procedure. Denote f½IRAS1ðiÞ‚IRAS2ðiÞ ‚
i ¼ 1‚ ...‚nhg as the pairs of IRAS values of a SNP for
nh heterozygous individuals. Assume that fIRAS1ðiÞ‚ i ¼
1‚ ...‚nhg follows a beta distribution with a probability
density function
fðyÞ¼½ Gða þ bÞ/GðaÞGðbÞ  · ya 1ð1 yÞ
b 1‚0< y < 1:
Based on the data for the 40 ﬂuorescent signals, we calculated
the IRAS of the heterozygous individuals, f½IRAS1ðiÞ‚
IRAS2ðiÞ ‚ i ¼ 1‚ ...‚nhg, as illustrated in Appendix 1. Let
the sample mean and standard deviation of fIRAS1ðiÞ‚
i ¼ 1‚ ...‚nhg be IRAS1 and SIRAS. Then, the moment esti-
mates of parameters a and b can be calculated as follows:
^ a a ¼f ½ IRAS1
2ð1   IRAS1Þ /SIRAS1g IRAS1 1
and
^ b b ¼f ½ IRAS1ð1   IRAS1Þ /SIRAS1g ð^ a a þ 1Þ: 2
Bootstrap samples were drawn from the empirical distribu-
tion Betað^ a a‚^ b bÞ. For the bth bootstrap sample, fIRASðbÞ
c ðiÞ‚
i ¼ 1‚ ...‚nh‚c 2 Cg, CPA was re-estimated to obtain ^ k kðbÞ.
The procedure was repeated L times to obtain f^ k kðbÞ‚
b ¼ 1‚ ...‚Lg. Finally, we took the sample standard devia-
tion of f^ k kðbÞ‚b ¼ 1‚ ...‚Lg to calculate the standard error
of the CPA estimator, i.e. S^ k k ¼½
PL
b¼1 ð^ k kðbÞ ~ k kÞ
2/ðL 1Þ 
1/2,
where ~ k k ¼
PL
b¼1 ^ k kðbÞ/L.
Appendix 3. The estimation of allele frequency in
a DNA pool
We calculated three types of allele frequencies for com-
parison, including the true, unadjusted and adjusted allele
frequencies. The true allele frequency was yielded by calcu-
lating the proportion of the number of a speciﬁc allele and
the total number of alleles based on individual genotyping
result. The unadjusted allele frequencies were estimated by
calculating the relative IRAS based on pooled allelotyping
result as follows:
^ p p
Unadjusted
1 ¼ IRASPool
1 /ðIRASPool
1 þ IRASPool
2 Þand
^ p p
Unadjusted
2 ¼ 1   ^ p p
Unadjusted
1 ‚
where fIRASPool
c ‚c 2 Cgdenoted the IRAS value of allele c in
a DNA pool. The adjusted allele frequencies were estimated
by incorporating the estimated CPA in the estimation of the
unadjusted allele frequency as follows:
^ p p
Adjusted
1 ¼ IRASPool
1 /ðIRASPool
1 þ ^ k k·IRASPool
2 Þ
and ^ p p
Adjusted
2 ¼ 1   ^ p p
Adjusted
1 :
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